Promega building new facility to support regulated product manufacturing

Promega Corporation breaks ground today for a “Current Good Manufacturing Practice” (cGMP) facility dedicated to accommodate business growth and its customers who need FDA-regulated molecular biology products. These include components such as sample preparation systems and reagents which are part of diagnostic and medical tests sold by human diagnostic test providers.

The 260,000 square feet facility will employ an additional 100 people in the next five years. Most of the building will be dedicated to manufacturing with both committed (fixed) production lines and flexible manufacturing areas. The building will also have a customer experience center for employees and guests that will include spaces for training, laboratory demonstrations, conferences, an exercise and fitness center, and dining.

“Molecular biology opens doors not only to new understanding of life, but to practical applications that enhance the health of our citizens,” says CEO Bill Linton. “We have a tremendous team at Promega who continue to diversify our capabilities to support the needs of our customers. This building is our next step in expanding our product supply capabilities worldwide.”